Submitted by Anonymous (not verified) on 23 June 2025 - 12:37
Human medicines European public assessment report (EPAR): Neuraceq, florbetaben (18F), Date of authorisation: 20/02/2014, Revision: 24, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Neuraceq, florbetaben (18F), Date of authorisation: 20/02/2014, Revision: 24, Status: Authorised